Connect with us

Hi, what are you looking for?

Economy

Sinovac vaccine is reasonably priced, Malacañang says

MALACAÑANG on Monday said the coronavirus vaccine the government would order from China’s Sinovac Biotech Ltd. was competitively priced.

One dose costs about P650, or P1,300 for the two doses needed by a person, presidential spokesman Harry L. Roque told an online news briefing. This is close to the price offered to Indonesia, he added.

He also said the reported P3,629 price for two doses reported to the Senate was “fake news.”

“I assure you, the price of Sinovac vaccines is lower than its commercial price in China,” Mr. Roque said.

The Philippines is in talks to order 25 million doses of Sinovac’s vaccine, and the first 50,000 doses are expected to arrive next month.

Mr. Roque said the government would disclose the negotiated price for the vaccines once the deal is finalized.

He said the state was not favoring any vaccine suppliers, adding that it was just a matter of which vaccine brands come first.

Mr. Roque also said President Rodrigo R. Duterte would have to decide whether to agree to be the first to be vaccinated in the country to address public doubt.

Meanwhile, Sinovac said it had given the Philippines a reasonable price for its coronavirus vaccine.

Sinovac General Manager Helen Yang said their vaccine is cheaper than what had been reported, without divulging the price due to confidentiality.

“I will assure you that this is a very good price that we provided to the Philippines,” she told CNN Philippines. She added that the deal with the government had not been finalized.

Senator Panfilo M. Lacson on Sunday said Sinovac vaccines in the Philippines could cost more than P1,800 a dose.

Sinovac is applying for emergency use authorization (EUA) in the country. — Kyle Aristophere T. Atienza and Vann Marlo M. Villegas

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest

Economy

WASHINGTON D.C. — The United States is seeking to form a coalition of countries to drive negotiations on a global plastic pollution treaty, weeks...

Economy

By Diego Gabriel C. Robles  THE WORLD BANK (WB) upgraded its growth forecast for the Philippines for this year and 2023, citing an “accommodative”...

Economy

THE PHILIPPINE auto industry’s sales recovery will likely be derailed if a measure reimposing excise taxes on pickup trucks is signed into law, according...

Economy

THE BANGKO SENTRAL ng Pilipinas (BSP) may deliver a second off-cycle rate hike in early November when the US Federal Reserve is expected to...

Economy

THE ASIAN Development Bank (ADB) is planning to allocate at least $14 billion for a program aimed at easing a food crisis in the...

Investing

With the reversal of the 1.25% rise in National Insurance Contributions happening on the 6th of November, employers across the nation have an opportunity...

You May Also Like

Investing

Having a good Instagram marketing agency to back up your Instagram account is an absolute must going into the new year. With competition stronger...

Investing

The minute that any question pops into your head, you can simply ask Google. No longer do we have to pour over books and...

Investing

Insomnia is the most common sleep disorder in the global population. Therefore, it is a problem that many people suffer or have suffered throughout...

Economy

Ivermectin, an existing drug against parasites including head lice, has had a checkered history when it comes to treating COVID-19. The bulk of studies...

Disclaimer: SmartRetirementReport.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 SmartRetirementReport. All Rights Reserved.